HEXO’s (TSX:HEXO) Stock Rebound Could Be Legendary

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is building a differentiated pot business capable of generating more than $1 billion in sales. A recent pullback could be your chance to strike.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

HEXO (TSX:HEXO)(NYSE:HEXO) was once one of the hottest stocks in the emerging cannabis industry. In 2016, shares were priced at just $0.50. This May, they topped $10.

The rise was incredible, but the recent cannabis bear market has hit the stock hard. Shares recently touched $2.50 apiece. To be fair, nearly every pot stock has been hit hard. Marijuana ETFs have fallen by more than 50% from their peaks.

Expectations for HEXO were certainly too high this summer, but following the decline, expectations now seem too low.

This fiscal year, analysts expect the company to generate $110 million in sales. Next fiscal year, analysts anticipate $230 million in sales. With a market cap of just $750 million, the stock is a screaming bargain if these projections come true.

And that’s just the next year or two. Over the long term, HEXO is building a differentiated business capable of generating at least $1 billion in sales.

Have to be different

This summer, I’d warned investors about the impending cannabis supply glut. “Take a look at most pot stocks, and you’ll discover one thing: the majority are trying to ramp cannabis production as quickly as possible,” I wrote. Indeed, weak pricing has been a major factor behind the recent market slump.

“The key to success will not be production growth,” I noted, “but differentiation.” Today, most pot companies are focused on proving why they’ll maintain pricing power, even as industry supply ramps. Canopy Growth, for example, is looking to create value-add, cannabis-infused beverages. Green Organic Dutchman Holdings has gone all-in on organic products.

But there are ways to differentiate yourself beyond building branded products. If you dig in, HEXO is building something truly special.

Building a giant

This decade, tech companies have perfected a model for creating multi-billion-dollar businesses: platforming. Microsoft and Shopify are popular examples. Microsoft, with its Windows operating system, and Shopify, with its e-commerce platform, have built products that other companies can build on top of.

Think of all the applications and businesses built on top of each respective platform. Without Microsoft or Shopify, they’d disappear instantly. That’s the power of a platform; it creates a super-sticky revenue model with intense customer retention.

Taking a cue from tech, HEXO is building the first cannabis platform. Instead of selling directly to consumers, the company is focused on building backend infrastructure capable of supporting the needs of other businesses.

Let’s say Coca-Cola wants to create cannabis-infused sodas, but doesn’t want to deal with the regulatory and capital-expense issues related to building its own private cannabis segment. Instead, it can simply partner with HEXO, which can use its existing infrastructure to research, develop, manufacture, package, and distribute Coke-branded cannabis products. It’s as simple as that.

Already, HEXO has attracted top-tier customers like Molson Coors Canada. In 2020, it wants to acquire additional Fortune 500 partners in new verticals like sleep aids, cosmetics, edibles, and more.

This hub and spoke model — with HEXO as the central hub and external partners as the spokes — is new to the cannabis industry, but it’s been proven in other markets. If it gains traction next year, HEXO stock could go gangbusters. That’s because it no longer needs to tap the market opportunity by itself. Instead, it’ll have pre-existing global partners ready to hit the ground running.

What’s more likely to succeed: a cannabis product from an upstart brand, or a cannabis product from a well-known global powerhouse? HEXO is betting on the latter.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Microsoft, Shopify, and Shopify. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »